TotalMarketCap

Enlivex

ENLVNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.946 M

$1.27 -8.63%

Close of 6 Nov 2026

As of 6 Nov 2026, Enlivex (ENLV) has a market capitalization of $1.95M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$1.24B

#332 by earnings

Shares outstanding

237,381,498

Latest filing cover page

P/E ratio

0.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #483Purple BiotechPPBT$2.02M
  2. #484GeoVax LabsGOVX$1.95M
  3. #485EnlivexENLV$1.95M
  4. #486Propanc BiopharmaPPCB$1.72M
  5. #487GenprexGNPX$1.70M

What if Enlivex were worth as much as…

Open the what-if tool →

Gold $28.2T

$18,431,437

Per share 14,512,942× higher

Bitcoin $1.53T

$997,292.94

Per share 785,270× higher

Apple $5.02T

$3,274,020

Per share 2,577,968× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Enlivex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.